000			04547nam a22003975i 4500
999			_c392704 _d392704 _x1
001			392704
003			ES-MaUEC
005			20240314174256.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			100301s2003 xxu| o |||| 0|eng d
020			_a9781592594047
024	7		_a10.1385/1592594042 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM345 _b2003 EB
245	0	0	_aCardiac Drug Development Guide _cedited by Michael K. Pugsley
250			_a1st edition 2003
264		1	_aTotowa, NJ _bHumana Press _c2003
300			_a1 recurso en línea (X, 431 páginas)
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Pharmacology and Toxicology _x1940-6053
505	0		_aCardiac Drug Development -- Novel Molecular Targets for Cardiac Drug Development -- The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discovery -- Oxygen Free Radicals in Heart Disease -- Mitogen-Activated Protein Kinases-Mediated Signaling in Cardiac Pathology -- Development of Anti-Inflammatory Drugs for Cardiovascular Disease -- Development and Use of Platelet Glycoprotein Antagonists in Heart Disease -- The Sodium-Hydrogen Exchange System in the Heart -- Nitric Oxide and Cardiac Ischemia -- Functional Endpoints Evaluating Cardiac Drug Activity -- Ionic Mechanisms of Atrial Fibrillation -- Targeting Ischemic Ventricular Arrhythmias -- Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease -- Heterologous Expression Systems and Screening Technologies in Ion Channel Drug Discovery -- Molecular Diversity of Ion Channels in the Mouse Heart -- Delayed Protection of the Myocardium -- Clinical Aspects in Cardiac Drug Development -- Cardiac Troponin Testing for Detection of Myocardial Infarction -- A Genetic Basis for Cardiac Arrhythmias -- Myocardial Adenoviral Vector Delivery for Cardiovascular Gene Therapy -- The Role of Pharmacometrics in Cardiovascular Drug Development -- Gender Differences in Heart Failure -- Angiogenesis Therapies for Coronary Artery Disease.
520			_aThe revolution in molecular medicine makes it imperative to integrate the classical and molecular approaches to drug development for the treatment of heart disease, the number one killer in North America and Europe. In the Cardiac Drug Development Guide, basic medical researchers, clinicians, and pharmacologists join forces to comprehensively survey the most recent breakthroughs in molecular cardiology and review the latest drug discoveries in cardiac and cardiovascular medicine. Topics range from novel molecular targets for cardiac drug development, to functional endpoints for evaluating cardiac drug activity, to clinical aspects of cardiovascular therapeutics. The authors describe the most advanced procedures in cardiovascular pharmacology, including in vivo and in vitro whole animal studies, the electrophysiological methods used to study pacemaker cells, and the application of biochemical principles and technologies to novel therapeutic agents. Also discussed are the methods used to express the ion channels involved in cardiovascular pharmacology, adenoviral vector delivery for cardiovascular gene therapy, pharmacometrics in cardiovascular drug development, gender differences in heart failure, and angiogenesis therapies for coronary heart disease. Each chapter concisely illustrates the concepts described and includes comprehensive background information, detailed figures and tables, and an up-to-date list of the most important references. Comprehensive and easy-to-understand, the Cardiac Drug Development Guide offers pharmacologists, cardiologists, and physiologists not only a gold-standard survey of the many different methods being used to develop new heart drugs, but also details powerful new ways in which cardiovascular disease is targeted, from the whole organ to the genetic level.
988			_aSpringer_Protocols_2003
650		7	_2embne _9158375 _aFarmacología cardiovascular
776	0	8	_iPrinted edition: _z9781489938282
776	0	8	_iPrinted edition: _z9781588290977
776	0	8	_iPrinted edition: _z9781489938275
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1592594042 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b01/2024 _dz _eIG _zSI